TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CAI

Caris Life Sciences, Inc.

Healthcare · Biotechnology · —

30.00$ -3.0% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

Caris Life Sciences, Inc. (CAI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 83 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow CAI
Line item 2013 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025
124 140 147 129 155 180 254 277 -286 -276 -245 83
68 79 114 107 113 123 114 111 48 49 49 23
1.5 1.9 1.9 1.7 2.1 2.9 2.8 1.8 23 15 19 70
-14 -78 31 45 -91 -86 417 -317 -22 -7.1 -29 -33
312 307 389 251 502 813 319 219 42 22 8.4 16
-267 -225 -305 -182 -412 -663 -272 -34 -283 215 53 -16
3.3 8.8 18
-31 -13 -9.2 -41 -34 -7.9 0.0 0.0 -0.1
-1.0 11 200 28
172 95 157 47 246 512 -108 -250 10 10 200 665
28 8.1 -1.3 -6.4 -11 29 -2.7 -6.7 -558 -51 8.0 732
-188 -168 -242 -122 -347 -633 -65 58 -328 -298 -254 67

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?